Skip to main content
· 1/11/2012

Fisher v. Pelstring

Citations

  • 817 F. Supp. 2d 791
  • 2012 U.S. Dist. LEXIS 18729
  • 2011 WL 4552464

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • denying summary judgment for generic manufacturer on claims for failure to update, fraud by concealment, manufacturing defect and breach of implied warranty of merchantability
  • admitting supplemental expert report when supplement \clarif[ied]\ earlier expert testimony and opposing party had opportunity to question expert regarding supplemental report
  • granting summary judgment for generic drug manufacturer on design defect claim when plaintiff failed to demonstrate existence of an alternative feasible design
  • denying summary judgment for generic manufacturer on claims for failure to update, fraud by concealment, manufacturing defect and breach of implied warranty of merchantability
  • denying motion to dismiss fraud claim when Plaintiffs alleged that generic drug manufacturer concealed facts by failing to include the 2004 warning in its label for metoclopramide
  • denying PLIVA’s motion for summary judgment on implied warranty of merchantability because “the Court does not find as a matter of law that long-term use was not an ordinary purpose for which metoclopramide was used”

Source: CourtListener parenthetical corpus (CC0).

Judges: Terry L. Wooten

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.